Active — Not RecruitingNot Applicable

Using Diagnostic Tools to Stage Breast Cancer

United States400 participantsStarted 2002-03-01

Plain-language summary

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women recently diagnosed with Breast Cancer * Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania Exclusion Criteria: * Contraindications to MRI * previously diagnosed with breast cancer (in the smae breast) within the past 5 years * Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy. * Pregnant women

Trial details

NCT IDNCT00367666

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03-12

View on ClinicalTrials.gov More Breast Cancer trials